What's on this Page
What is Umeclidinium (Incruse Ellipta)
Umeclidinium is a respiratory antimuscarinic (anticholinergic), often referred to as a long-acting muscarinic antagonist (LAMA), that is used once a day.
It is FDA-approved for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, umeclidinium may be used as initial monotherapy in all groups of COPD patients; however, combination therapy with a long-acting beta-agonist (LABA) or inhaled corticosteroid (ICS) may be needed in patients in Group D or in patients still experiencing dyspnea or exacerbations upon follow-up
Brand Name
INCRUSE ELLIPTA
Indications
- chronic bronchitis
- chronic obstructive pulmonary disease (COPD)
- emphysema
Side Effects
- abdominal pain
- anaphylactoid reactions
- angioedema
- arthralgia
- atrial fibrillation
- blurred vision
- bronchospasm
- conjunctivitis
- constipation
- cough
- depression
- diarrhea
- dizziness
- dyspepsia
- ecchymosis
- headache
- infection
- myalgia
- nausea
- ocular hypertension
- pharyngitis
- pruritus
- rash
- rhinitis
- sinus tachycardia
- supraventricular tachycardia (SVT)
- urinary retention
- urticaria
- vertigo
- wheezing
- xerostomia
Monitoring Parameters
- pulmonary function tests (PFTs)
Contraindications
- acute bronchospasm
- angioedema
- anticholinergic medications
- bladder obstruction
- breast-feeding
- children
- closed-angle glaucoma
- contact lenses
- geriatric
- infants
- milk protein hypersensitivity
- neonates
- ocular exposure
- ophthalmic administration
- paradoxical bronchospasm
- pregnancy
- prostatic hypertrophy
Interactions
- Aclidinium
- Aclidinium; Formoterol
- Anticholinergics
- Brigatinib
- Daclatasvir
- Darunavir
- Darunavir; Cobicistat
- Darunavir; Cobicistat; Emtricitabine; Tenofovir alafenamide
- Fosamprenavir
- Glecaprevir; Pibrentasvir
- Isavuconazonium
- Lumacaftor; Ivacaftor
- Methacholine
- Mirabegron
- Osimertinib
- Peginterferon Alfa-2b
- Rolapitant
- Sapropterin
- Sofosbuvir; Velpatasvir; Voxilaprevir
- Sorafenib
- Temsirolimus
- Trandolapril; Verapamil
- Verapamil
